Chemotherapy and regional therapy of hepatic colorectal metastases: Expert consensus statement

被引：37
作者：
Bartlett, David L.
Berlin, Jordan
Lauwers, Gregory Y.
Messersmith, Wells A.
Petrelli, Nicholas J.
Venook, Alan P.
机构：
[1] Helen F Graham Canc Ctr, Dept Surg, Newark, DE 19713 USA
[2] Univ Pittsburgh, Div Surg Oncol, Pittsburgh, PA USA
[3] Vanderbilt Ingram Canc Ctr, Div Internal Med & Med Oncol, Nashville, TN USA
[4] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Gastrointestinal Oncol Program, Baltimore, MD USA
[7] Helen F Graham Canc Ctr, Dept Surg, Newark, DE 19713 USA
[8] Univ Calif San Francisco, Dept Clin Med, San Francisco, CA 94143 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2006年 / 13卷 / 10期
关键词：
colorectal metastases; unresectable metastases; adjuvant chemotherapy; liver resection; intra-arterial chemotherapy; drug-related hepatotoxicity; snusoidal injury; steatosis; steatohepatitis; nodular regeneration; biliary sclerosis;
D O I：
10.1245/s10434-006-9018-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1284 / 1292
页数：9
相关论文
共 72 条
[1]  
ADAM R, COMMUNICATION
[2]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[3]   Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview [J].
Barber, FD ;
Mavligit, G ;
Kurzrock, R .
CANCER TREATMENT REVIEWS, 2004, 30 (05) :425-436
[4]   Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer [J].
Bartlett, DL ;
Libutti, SK ;
Figg, WD ;
Fraker, DL ;
Alexander, HR .
SURGERY, 2001, 129 (02) :176-187
[5]   Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection [J].
Behrns K.E. ;
Tsiotos G.G. ;
DeSouza N.F. ;
Krishna M.K. ;
Ludwig J. ;
Nagorney D.M. .
Journal of Gastrointestinal Surgery, 1998, 2 (3) :292-298
[6]   Should Dukes' B patients receive adjuvant therapy? A statistical perspective [J].
Buyse, M ;
Piedbois, P .
SEMINARS IN ONCOLOGY, 2001, 28 (01) :20-24
[7]   An update on hepatic arterial infusion chemotherapy for colorectal cancer [J].
Cohen, AD ;
Kemeny, NE .
ONCOLOGIST, 2003, 8 (06) :553-566
[8]   Evaluating the clinical and economic trade-offs of hepatic arterial infusion [J].
Cole, BF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (05) :223-224
[9]   Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A Multicenter study of the Gruppo Oncologico Dell'Italia Meridionale [J].
Colucci, G ;
Gebbia, V ;
Paoletti, G ;
Giuliani, F ;
Caruso, M ;
Gebbia, N ;
Carteni, G ;
Agostara, B ;
Pezzella, G ;
Manzione, L ;
Borsellino, N ;
Misino, A ;
Romito, S ;
Durini, E ;
Cordio, S ;
Di Seri, M ;
Lopez, M ;
Maiello, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4866-4875
[10]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
12345678